 ROCHESTER, N.Y., Jan. 14, 2021 GLOBE NEWSWIRE -- Document Security Systems, Inc. DSS or the Company NYSE American: DSS, a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. Impact BioMedical received notice of allowance from the U.S. Patent and Trademark Office USPTO for a methodcomposition patent for its proprietary 3F Biofragrance. 